NO942350L - Peptidforbindelse med terapeutisk aktivitet - Google Patents

Peptidforbindelse med terapeutisk aktivitet

Info

Publication number
NO942350L
NO942350L NO942350A NO942350A NO942350L NO 942350 L NO942350 L NO 942350L NO 942350 A NO942350 A NO 942350A NO 942350 A NO942350 A NO 942350A NO 942350 L NO942350 L NO 942350L
Authority
NO
Norway
Prior art keywords
therapeutic activity
peptide compound
ahx
ile
phe
Prior art date
Application number
NO942350A
Other languages
English (en)
Norwegian (no)
Other versions
NO942350D0 (Direct
Inventor
Myles Edward Pierson
James Donald Rosamond
Original Assignee
Fisons Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929220543A external-priority patent/GB9220543D0/en
Priority claimed from GB929220761A external-priority patent/GB9220761D0/en
Application filed by Fisons Corp filed Critical Fisons Corp
Publication of NO942350D0 publication Critical patent/NO942350D0/no
Publication of NO942350L publication Critical patent/NO942350L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/595—Gastrins; Cholecystokinins [CCK]
    • C07K14/5955—Gastrins; Cholecystokinins [CCK] at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO942350A 1991-12-20 1994-06-20 Peptidforbindelse med terapeutisk aktivitet NO942350L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US81098591A 1991-12-20 1991-12-20
GB929220543A GB9220543D0 (en) 1992-09-29 1992-09-29 Pharmacologically active compounds
GB929220761A GB9220761D0 (en) 1992-10-02 1992-10-02 Pharmaceutically active compounds
PCT/GB1992/002369 WO1993013126A1 (en) 1991-12-20 1992-12-21 Peptide compounds having therapeutic activity

Publications (2)

Publication Number Publication Date
NO942350D0 NO942350D0 (Direct) 1994-06-20
NO942350L true NO942350L (no) 1994-06-20

Family

ID=27266393

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942350A NO942350L (no) 1991-12-20 1994-06-20 Peptidforbindelse med terapeutisk aktivitet

Country Status (11)

Country Link
EP (1) EP0619823A1 (Direct)
JP (1) JPH08500324A (Direct)
AU (1) AU672186B2 (Direct)
CA (1) CA2126236A1 (Direct)
FI (1) FI942898L (Direct)
HU (1) HU211564A9 (Direct)
IL (1) IL104161A0 (Direct)
MX (1) MX9207458A (Direct)
NO (1) NO942350L (Direct)
NZ (1) NZ246195A (Direct)
WO (1) WO1993013126A1 (Direct)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7762610B2 (ja) * 2022-03-28 2025-10-30 雪印メグミルク株式会社 アンジオテンシン変換酵素阻害ペプチド

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE754248R (fr) * 1969-08-01 1971-02-01 Farmaceutici Italia Polypeptides a activite
NZ218607A (en) * 1985-12-19 1989-10-27 Pennwalt Corp Tri-to acta-peptides with sulphate ester groups: obesity treatment
IE873084L (en) * 1986-11-18 1988-05-18 Pfizer Hospital Prod Peptides with sulfate ester groups
KR927003630A (ko) * 1989-11-27 1992-12-18 씨 비 크레이그 황산 에스테르기를 갖는 헥사펩티드

Also Published As

Publication number Publication date
JPH08500324A (ja) 1996-01-16
FI942898A7 (fi) 1994-06-17
IL104161A0 (en) 1993-05-13
NO942350D0 (Direct) 1994-06-20
HU211564A9 (en) 1995-12-28
FI942898A0 (fi) 1994-06-17
FI942898L (fi) 1994-06-17
AU3167893A (en) 1993-07-28
WO1993013126A1 (en) 1993-07-08
NZ246195A (en) 1995-11-27
MX9207458A (es) 1993-11-01
AU672186B2 (en) 1996-09-26
CA2126236A1 (en) 1993-07-08
EP0619823A1 (en) 1994-10-19

Similar Documents

Publication Publication Date Title
DE69831868D1 (en) Antithrombosemittel
IL133623A0 (en) Antithrombotic agents
ATE374749T1 (de) Indol-derivate als antientzündungs wirkstoffe
ES2132393T3 (es) Derivados de guanidina utiles en terapeutica.
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
DE3785136D1 (de) Arzneimittel zur inhibition von hautfalte.
MY123908A (en) Meta-azacyclic amino benzoic acid compounds and derivatives thereof
ES2161238T3 (es) Uso de 2-fenil-3-aroilbenzotiofenos para la preparacion de un medicamento para inhibir la angiogenesis y enfermedades angiogenicas.
ES2154669T3 (es) Uso de 2-fenil-3-aroilbenzotiofenos para la preparacion de un medicamento para la inhibicion de la degradacion del cartilago.
NO944933L (no) Fremgangsmåte for å inhibere sykdomstilstander i brystet
ES2111352T3 (es) Uso de diester fosfato para el tratamiento de enfermedades retinianas.
ZA922910B (en) Heterocylic pharmaceutical compounds preparation and use
NO944923L (no) Hemming av vektökning eller indusering av vekttap
LU90732I2 (en) Synercid
ATE200291T1 (de) Cephemderivate
NO942350L (no) Peptidforbindelse med terapeutisk aktivitet
MY111439A (en) Thymosin alpha 1 derivatives
ATE282608T1 (de) Chinoxalindionen
NO974651L (no) Biologisk aktive ureidoderivater som er nyttige i behandlingen av multippel sklerose
NO303817B1 (no) Tiokarbamatsulfoksydsammensetning for avholdenhet fra inntakelse av etanol
SE9201188L (sv) Ny användning
DE69528984D1 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten
DK0674645T3 (da) Cephemforbindelser med antimikrobiel virkning
IL116557A0 (en) Antiherpes peptidomimetic compounds their preparation and pharmaceutical compositions containing them
ATE10934T1 (de) Peptid, verfahren zu dessen herstellung und dessen verwendung.